Things got chippy when the Wolverines tried to keep MSU players from their traditional smooch of the Spartans logo ...
5d
USA TODAY College Sports Wire on MSNWatch different angles of Tre Holloman protecting MSU's logo tradition vs. MichiganYou can check out all the angles and footage of Tre Holloman protecting MSU's senior logo-kissing tradition vs. Michigan here ...
5d
Spartans Wire on MSNBest reactions to MSU's win over Michigan, Tre Holloman logo tradition confrontationSocial media was on fire after Michigan State beat U of M after Tre Holloman defended the logo tradition from some Michigan players ...
5d
Spartans Wire on MSNTom Izzo comments on Michigan State's win over Michigan, logo tradition dust-upHere's what Tom Izzo had to say about his team's win over Michigan and the incident surrounding the logo tradition at the end of the game ...
With 37 seconds remaining, MSU forward Frankie Fidler came out of the game and kissed the Spartan logo, as Michigan guards L.J. Cason and Phat Phat Brooks stood nearby at center court ...
Arcus Biosciences (RCUS) announced that Gilead’s (GILD) time-limited exclusive option rights to casdatifan have expired. In addition, Arcus has announced the pricing of a $150 million common ...
Truist Financial analyst Asthika Goonewardene maintained a Buy rating on Arcus Biosciences (RCUS – Research Report) today. The company’s shares closed last Friday at $13.10. See what stocks ...
Gilead Sciences has defied analysts’ expectations by passing on its chance to license Arcus Biosciences’ potential rival to Merck & Co.’s kidney cancer drug Welireg. Gilead had the right to ...
Tom Izzo is proud of Tre Holloman for not backing down. Late in Michigan State's 79-62 thrashing of Michigan on Sunday, Holloman confronted two Wolverines players who were standing on the Spartans ...
5d
The Spun on MSNMichigan Players Accused Of 'Disrespecting' Michigan State LogoThings got heated between Michigan and Michigan State's players at the end of Sunday afternoon's rivalry game in East Lansing ...
HAYWARD, Calif., February 18, 2025--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results